Advances in proteomic phenotyping of microglia in neurodegeneration
- 2 May 2023
- journal article
- review article
- Published by Wiley in Proteomics
- Vol. 23 (13-14) , e2200183
Abstract
Microglia are dynamic resident immune cells of the central nervous system (CNS) that sense, survey, and respond to changes in their environment. In disease states, microglia transform from homeostatic to diverse molecular phenotypic states that play complex and causal roles in neurologic disease pathogenesis, as evidenced by the identification of microglial genes as genetic risk factors for neurodegenerative disease. While advances in transcriptomic profiling of microglia from the CNS of humans and animal models have provided transformative insights, the transcriptome is only modestly reflective of the proteome. Proteomic profiling of microglia is therefore more likely to provide functionally and therapeutically relevant targets. In this review, we discuss molecular insights gained from transcriptomic studies of microglia in the context of Alzheimer's disease as a prototypic neurodegenerative disease, and highlight existing and emerging approaches for proteomic profiling of microglia derived from in vivo model systems and human brain.Keywords
Funding Information
- National Institutes of Health (F31AG071319, F31AG074665, 1F31NS127530, R01AG075820, R01NS114130, RF1AG071587)
This publication has 213 references indexed in Scilit:
- Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent MannerNeuron, 2012
- Insights into the regulation of protein abundance from proteomic and transcriptomic analysesNature Reviews Genetics, 2012
- A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cellsJournal of Cell Biology, 2012
- The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOENeurobiology of Aging, 2012
- Effects of aging and sensory loss on glial cells in mouse visual and auditory corticesGlia, 2012
- Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's diseaseNature Genetics, 2011
- Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's diseaseNature Genetics, 2011
- Age‐related alterations in the dynamic behavior of microgliaAging Cell, 2010
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's diseaseNature Genetics, 2009
- Selective identification of newly synthesized proteins in mammalian cells using bioorthogonal noncanonical amino acid tagging (BONCAT)Proceedings of the National Academy of Sciences, 2006